Arbatin Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201900171 · Approved 2019.01.14
This product's status changed to Expired on 2024.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including pediatric familial hypercholesterolemia); prevention of cardiovascular disease (e.g., myocardial infarction)
This medication is used to reduce the risk of cardiovascular disease. It decreases the risk of myocardial infarction, stroke, need for vascular interventions, angina, and hospitalization for congestive heart failure in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. It also effectively helps improve cholesterol and lipid levels in patients with primary hypercholesterolemia or mixed dyslipidemia, dysbeta-lipoproteinemia, and hypertriglyceridemia. It can be safely used in pediatric patients aged 10 to under 17 years with hypercholesterolemia persisting despite dietary measures. This medication is used to manage risk factors for cardiovascular disease and improve cholesterol levels to enhance overall heart health.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg once daily or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in older patients aged 70 years and over are generally similar to those in the general adult patient population.
2. Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age) The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug higher than 20 mg in pediatric patients.). The dose should be appropriately increased or decreased according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause unusual muscle symptoms, and if severe muscle pain or weakness occurs or creatine kinase levels rise significantly, it should be discontinued immediately. Patients with impaired liver function or active liver disease should not use this medication. Patients with muscle disorders or suspected muscle disorders, pregnant or potentially pregnant women, children under 10 years of age, and patients taking certain medications should also avoid using this medication. Patients with a history of alcohol dependence or liver disease should use this medication cautiously, and those at risk for muscle issues should have their muscle enzyme levels checked before treatment. This medication is generally safe, but side effects such as muscle pain, dyspepsia, headache, allergic reactions, and liver function abnormalities may occasionally occur, so consultation with a physician is advisable if symptoms worsen. Taking this medication in conjunction with certain antibiotics, antifungals, and antiviral agents may increase blood concentration and risk of side effects; therefore, inform your physician of any concomitant medications. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception while on treatment. Elderly patients or those with reduced kidney function are at higher risk for muscle-related side effects, so careful administration under physician guidance is necessary. In case of overdose, there is no specific antidote, so symptomatic treatment should be given, and liver function and muscle enzymes should be monitored regularly. Keep this medication out of reach of children, store it in its original container, and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. Additionally, avoid extremely hot or cold places, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.